Skip to main content
. Author manuscript; available in PMC: 2012 Oct 8.
Published in final edited form as: Ann Thorac Surg. 2012 Jul 12;94(4):1079–1085. doi: 10.1016/j.athoracsur.2012.05.048

Table 2.

Association of Genotypes in VEGF Pathway With Pulmonary Complications

Gene SNP Chromosome Model of Inheritance Discovery Set
Replication Set
Pooled Analysis
ORa (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value
FLT1 rs9319425 13 Additive 1.48 (1.01–2.17) 0.04 1.53 (1.05–2.24) 0.03 1.50 (1.15–1.96) 0.003
NRAS rs10489525 1 Additive 0.66 (0.41–1.05) 0.08 0.56 (0.36–0.88) 0.01 0.62 (0.46–0.86) 0.004
RAF1 rs713178 3 Recessive 0.13 (0.02–1.14) 0.07 0.30 (0.06–1.45) 0.13 0.19 (0.05–0.70) 0.01
VEGFB rs2429455 11 Additive 0.68 (0.43–1.05) 0.08 0.78 (0.52–1.16) 0.21 0.72 (0.54–0.97) 0.03
VEGFC rs3775195 4 Recessive 2.57 (1.03–6.40) 0.04 2.00 (0.66–6.05) 0.22 2.18 (1.08–4.39) 0.03
FLT4 rs307811 5 Recessive 2.33 (1.05–5.17) 0.04 1.42 (0.64–3.13) 0.39 1.84 (1.05–3.21) 0.03
a

OR = odds ratio adjusted for age at operation, sex, intraoperative transfusion, % DLCO predicted, and chest wall resection.

DLCO = diffusing capacity of lung for carbon monoxide; CI = confidence interval; SNP = single nucleotide polymorphism; VEGF = vascular endothelial growth factor.